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Introduction
In the European Union (EU) a growing number of
EU citizens are receiving medical treatment in a
country other than the one in which they are resi-
dent. This situation particularly concerns migrant
workers, persons benefiting from double access to
health care (E106), travellers going to another state
for temporary stay (tourism, short-term work, study)
and who need immediate necessary care (E111), and
patients who obtain prior authorization for medical
treatment in another Member State by their compe-
tent institution (E112).
Cross-border care is regulated at EU level using
the basic principles of European and international
(health) law, the European Community (EC) and
European Economic Area (EEA) Treaties, in par-
ticular the free movement of persons (in the latest
version, Article 39 EC Treaty), and the EC Regula-
tions on the co-ordination of social insurance 1408/71
and 574/72. Since 1998 a ‘new category’ can be dis-
cerned of insured persons going abroad for medical
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Abstract
In the European Union a growing number of citizens are receiving medical
treatment in a country other than the one in which they are resident.
This concerns migrant (frontier) workers, emergency treatment and 
preauthorized care. Since 1998 a ‘new category’ can be discerned of persons
going abroad without prior authorization on the basis of the Decker and
Kohll rulings of the EC Court of Justice. Local payers would, because of
the Decker and Kohll judgements, be obliged to reimburse patients who
travel abroad to circumvent the existing problems with the authorization
rules.
During the past years studies within specific so-called Euregions have
been performed to analyse cross-border flows and provide some more
insight in the practical and health policy consequences of the Decker and
Kohll judgements. The abolishment of current preauthorization is pleaded
for by many respondents in these studies. Waiting lists form an important
motive (in particular in the Netherlands) to consume health care in another
Member State (Belgium and Germany). The familiarity with (health care
in) Belgium eases the unofficial Decker and Kohll route. However, when
some parts of the health care services seem to be more expensive in the
other Member State, the patient has to pay the difference. New court cases
are pending before the European Court of Justice. These cases raise new
issues such as the tenability of ‘benefits-in-kind’ systems. So far, the Decker
and Kohll rulings could be seen as an incentive to enhance access to cross-
border health care in border areas.
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treatments without prior authorization and claiming
reimbursement after returning to their country of
origin on the basis of the Decker and Kohll rulings
of the EC Court of Justice.
According to Article 18.1 of the EC Treaty: ‘Every
citizen of the Union shall have the right to move and
reside freely within the territory of the Member
States, subject to the limitations and conditions laid
down in this Treaty and by the measures adopted to
give it effect.’
This paper focuses on the cross-border care of
patients and insured persons visiting other Member
States and falling under the social health insurance
system (or the national health service) of the country
of origin and focuses in particular on the conse-
quences of ‘Decker and Kohll’ rulings of the Court
of Justice of the European Community in the border
regions of Belgium, Germany and the Netherlands.
What are the legal consequences for patients of 
these cross-border movements? Could the judge-
ments be regarded as threats for the national health
care systems or just as challenges for improving the 
right to access for patients of medical services in 
the EU?
The paper presents some empirical data of two
recent cross-border health care projects in the border
regions of Belgium, Germany and the Netherlands.
Within these projects experiments have been set up
on the basis of the existing legislation that guaran-
teed patients easier access to health care services
abroad. However, these experiments do not prevent
patients seeking medical treatments or buying prod-
ucts directly and without preauthorization in other
Member States on the basis of the Decker and Kohll
rulings of the European Court. Therefore, should
these ‘Decker and Kohll’ rulings and new cases be
regarded as incentives to enhance access to cross-
border care or will they lead to considerable prob-
lems for both patients and the existing health care
systems in the European Union?
Cross-border health care: some 
general aspects
Individual Member States of the EU are, in princi-
ple, exclusively responsible for the provision of
health services within their national boundaries.
Unlike public health, health care is not defined
specifically as a European responsibility in the
Treaties of the EU. However, many formal EU policy
areas contain provisions which impact on health 
care. Medical treatment received by EU citizens in a
Member State other than the one in which they pay
social security contributions is regulated by EU law.
Regulations 1408/71 and 574/72 of the European
Commission (1971, 1972) cover access to health care
for workers and their families. The context for the
development of these regulations, which provided for
the preservation and co-ordination of national social
security rights across EU Member States, was the
need to ensure and promote the mobility of frontier
workers. Originally, such regulatory provisions con-
sisted of bilateral agreements between states. As
more states became involved these agreements came
to be organized multilaterally on the basis of the
European Economic Community (EEC) Treaty and
EEC Regulations, supplemented by continuing bilat-
eral agreements. In December 1998 the European
Commission (1998) presented a proposal for a 
new Regulation to update no. 1408/71 which would
provide the extension of existing provisions to all
persons covered by the social security legislation of
a Member State.
The currently existing European Coordination
Regulations 1408/71 and 574/72 permit three types 
of cross-border care: for migrant (mostly frontier)
workers, emergency treatment during temporary
stays, and preauthorized care.
Frontier workers benefit from double access 
to health care, simultaneously in both their state of
residence and in the state in which they work. To 
initiate this right in the state of residence an E106
form is issued. In some cases, as with frontier workers
between France and Belgium, this double access has
been extended by bilateral agreement to family
members.
The EU Regulations also provide for mechanisms
for individuals to access health care abroad in emer-
gency situations. It applies for tourist mobility and
short-term business and professional mobility. The
E111 form provides for emergency treatment for 
citizens of one EU State while they are visiting
another. A condition for this type of care is that the
person’s state of health necessitates immediate care
(Regulation 1408/71, Article 22, 1, a).
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In cases where patients obtain prior authorization
by their national social insurance authority, persons
falling under the scope of the co-ordination rules can
obtain medical treatment in another Member State.
In those cases the treatment will be paid for by their
national social insurance authority (Regulation
1408/71,Article 22, 1, b and c). Form E112 proves that
the authorization has been given by the competent
Institution. Article 22 of Regulation 1408/71 contains
a clause which states that authorization cannot be
refused in situations where treatment is available in
the home state but cannot be provided within a
normal time period, taking into account the patient’s
state of health.
Until recently the authorization policy remained
largely a prerogative of national Member States.
Cross-border health policy has traditionally been the
responsibility of each Member State on the basis 
of the principle of subsidiarity (Article 5 of the EC
Treaty). Subsidiarity empowers national govern-
ments to determine health policy within their
national borders.
Implications of the Decker and 
Kohll judgements
The economic integration and the internationaliza-
tion of capital and labour markets including the free
movement of capital, persons, goods, and services,
increased population mobility and the international
division of labour in the health care sector on the
European continent (Kyriopoulos et al. 1994). This
should also include the pricing of medical goods and
services, levels of reimbursement, and types and
levels of co-payment.
The Decker and Kohll judgements of the 
European Court of Justice concerning the treatment
of citizens of one Member State in another Member
State introduced an entirely new dimension in 
European health policy making. For the first time, the
court’s rulings have made mainstream health services
subject to two of the principles on which the EU was
founded: the freedom of the movement of goods and
the freedom of the movement of services. Health 
care is now deemed to be tradable and, thus, subject
to the EC Treaty, thereby constraining the powers of
national payers or providers.The implications of both
these cases for health policy could be quite com-
pelling in the short term and far-reaching in the 
long-run.
In the first case (European Court of Justice 1998a)
a Luxembourg health insurance fund refused to
reimburse its insuree for the cost of a pair of specta-
cles. The court ruled that the refusal to reimburse
goods purchased in another Member State was
against the EC Treaty which covers the free move-
ment of goods.
In the second Court ruling (European Court of
Justice 1998b) the Court upheld the right of a citizen
of Luxembourg to obtain and be reimbursed for
dental treatment in Germany also without seeking
prior authorization of his Luxembourg social insur-
ance Institution. The Court rendered health services
as ‘tradable’ and available to all EU citizens regard-
less of their country of residence or their health
insurance status or insurance fund.
While the Kohll ruling allows citizens of one
Member State to seek medical treatment in another
Member State without prior authorization from their
health authority or insurance fund it also gives due
consideration to reimbursement of the services 
delivered by the health insurance of the patients’
country of residence. Thus, reimbursement of
patients will take place according to the rules pre-
vailing in the patients’ country.
To the extent that patients are allowed to move
freely across borders without prior authorization, the
ruling improves on existing regulations involving 
the E111 and E112 forms for transnational patients.
However, there is still confusion as to whether the
right applies to both ambulatory and hospital 
services.
The Decker and Kohll judgements have, thus,
resulted in the present cohabitation of two systems
for seeking reimbursable cross-border care: con-
tinued use of Regulation 1408/71 which provides for
full payment of charges incurred by the insured
persons with a prior authorization (E112), and a
direct right based on the EC Treaty and be reim-
bursed in accordance with the scale of the State of
insurance.
What are the present motives for patients seeking
health care treatments abroad and are any increases
in the volume of patients seeking care in another
Member State already occurring or expected to occur
as a result of these judgements?
Cross-border health care in the European Union
© 2000 Blackwell Science, Journal of Evaluation in Clinical Practice, 6, 4, 431–439 433
H.E.G.M. Hermans
Motives and consequences of cross-border
health care
Cross-border health care occurs where specialized
care is not (sufficiently) available in one Member
State but can be obtained in another; when waiting
lists are significantly shorter elsewhere and when
elective care is significantly less expensive across the
border (Leidl & Rhodes 1997). Local payers, using
local capacity control as a mechanism for cost control
would, because of the Decker and Kohll judgements,
be obliged to reimburse patients who travel abroad
to circumvent these problems. This could involve
increased expenditures by local payers. The losers as
a consequence of the rulings could not only be local
payers, but also local providers since care provided
abroad would imply loss of income for them.
Other motives for cross-border care include the
increasing mobility of citizens due to tourism, busi-
ness and short-term stays. Cross-border care is also
of interest when workers live near the border of one
Member State and work in another. It might also be
highly relevant in emergency cases where patients
are unable to receive timely and qualitatively appro-
priate care within their own national health care
systems (Hermans 1999).
Finally, an increase in the volume of patients
seeking care in another Member State may be due to
differences in the perceived quality of the services.
According to a recent study on the role of the EU in
health care (produced at the request of the Dutch
Council for Health and Social Service) one key factor
influencing a patient’s decision to seek health care
abroad is the level of satisfaction with the domestic
system (Belcher 1999). Italians, for instance, are 
particularly dissatisfied with treatment provided in
Italy and have high expectations of what is available
abroad (France 1997).
Cross-border practices between Belgium,
Germany and the Netherlands
Although the aforementioned motives for cross-
border health care seem to be strong, in practice the
totality of flows of patients is small within the EU
(Hermesse et al. 1997). However, as the Decker and
Kohll cases have highlighted, the EU could have an
increasing impact on the cross-border provision and
availability of health care. At present, cross-border
flows of patients are concentrated in particular 
European border regions for reasons such as linguis-
tic similarity or perception of the domestic health
system vis-à-vis that available abroad. Traditionally,
flows have been greatest between Belgium, France,
Germany, Italy, the Netherlands and Luxembourg.
During the past years a few studies have been per-
formed to analyse cross-border flows for individual
Member States, in particular within specific so-called
Euregions. These studies could provide some more
insight in the practical and health policy conse-
quences of the Decker and Kohll judgements.
Cross-border health care in the 
‘Euregio Meuse-Rhine’
On behalf of the European Commission, and within
the Inter-regional (Interreg II) programme, a cross-
border health care project has been set up to explore
how citizens living in the ‘Euregion Meuse-Rhine’
could obtain improved access to health services in
the Member States concerned. The ‘Euregio Meuse-
Rhine’, being one of the more than 60 Euregions in
the EU involves a part of Belgium, Germany and the
Netherlands and, moreover, three languages: Dutch,
German and French. Approximately 3.7 million
people live in this Euregion. More specifically, it 
consists of parts of the Dutch province of Limburg
(Middle and South of Limburg); the province 
of Limburg (Belgium); the province of Liège
(Belgium), including the German-speaking com-
munity, and the former district of the federal state
Aachen (‘ehemalig Regierungsbezirk Aachen’) in
Germany.
This project stimulated (contractual) relationships
between purchasers (Dutch sickness funds, German
‘Krankenkassen’ and Belgian mutualities) and pro-
viders to make arrangements on behalf of patients
living in the Euregion. On the side of health insurers
initiatives have been started on reducing barriers for
patients, such as creating possibilities of a flexible
application of the forms E111, E112 and (recently
E128) which are needed in cases of cross-border
health care (Hermans & Ghajar 1999).
In the Interreg II programme, a project IZOM was
introduced in which a registration system of the exist-
ing cross-border health care by monitoring patients
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who received preauthorized care in the neighbouring
countries on an experimental basis in which the 
existing regulations (E112) had been eased. At the
beginning of 1999 the IZOM-project started in 
the Euregion Meuse-Rhine and was completed in
December 1999 (Ghajar and Hermans 1999). The
research focused not only on Dutch insured persons
who crossed the Belgian and German borders to use
health care services in the other Member States, but
also the other way around. In this research reciproc-
ity was a basic requirement. In total 281 persons par-
ticipated in the research. From this total number of
social insured persons 27% had Belgian nationality,
25% German nationality and 46% Dutch nationality.
However, making a distinction between nationality
and country of residence it appears that a major part
of the participants live in a country other than their
country of nationality (Table 1).
Most of the insured persons who participated in
this study are between 50 and 59 years of age. Most
respondents were informed about cross-border care
by their family, friends and relatives (36.6%) and
34.4% by their referring GP (14%) or medical 
specialist (20%). From the total number of 281 par-
ticipants, 155 (55.2%) indicated that they have been
treated abroad before. Most of them were very
content with their previous treatment. Some 11.5%
had had a bad experience with reimbursement of 
the care or treatment that they received abroad. In
most cases where preauthorization of a previous
treatment was refused to those insured by their com-
petent health insurer, the refusal was based on the
argument that the treatment was also possible in the
country of residence, because the speciality was not
recognized by the sickness fund, and because the
person concerned did not carry his E112. It is impor-
tant to analyse for what kind of care patients go
abroad, and what their main reason is for crossing the
border.
From Table 2 it can be seen that ‘distance’ is, for
seven of the specialties, the main reason for being
treated abroad (25.3%). ‘Better treatment’ is second
with 15.7%. General surgery (17.5%), gynaecology
(15.3%) and orthopaedics (13.1%) are the main
other types of care patients crossing borders are
being treated for.
‘Distance’ is not always the main reason to be
treated abroad. When a further distinction between
nationality and country of residence is made, ‘waiting
time’, ‘language’ and ‘recommended by the specialist’
are also important indicators of choice of whether or
not to consume health care in another Member State.
Insured persons are mostly going abroad for general
surgery and gynaecology, while pensioners generally
require ophthalmology and general surgery.
The respondents were also asked for recommen-
dations and improvements of the present system.
A large number of respondents pleaded for more
freedom of choice, abolition of the present pre-
authorization system, a faster, more simplified 
administration, and less bureaucracy. An important
recommendation of some respondents was to keep
their own GP when moving to another country, and
the creation of the possibility to keep their own
dentist.
Conclusions from this study are that general
surgery, gynaecology and orthopaedics are the main
types of care for respondents to go abroad for.
The combination of nationality and country of re-
sidence shows that ‘waiting time’ is the main reason
for Dutch respondents and Germans living in the
Netherlands. For Belgians who also live in Belgium
‘recommended by the specialist’ is their main 
motivation.
As a consequence of the Decker and Kohll judge-
ments it could be argued that, in the Netherlands,
waiting times in particular could form a strong incen-
tive to be treated abroad without preauthorization.
Cross-border health care in the European Union
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Table 1 Country of residence and nationality
Country of residence
Belgium The Netherlands Germany Total
Nationality
Belgian 74 1 1 76
Dutch 47 76 5 128
German – 58 14 72
Other 5 – – 5
Total 126 135 20 281
Source: Ghajar S. & Hermans H.E.G.M. (1999) IZOM, Behoefte van
verzekerden aan grensoverschrijdende zorg en hun ervaringen
[Needs of insured persons for cross-border care and their experi-
ences], Eindrapport inzake het project Integratie Zorg op Maat in
Interreg II, Euregio Maas-Rijn [Final Report concerning integration
Zorg op Maat in Interreg II], Rotterdam
H.E.G.M. Hermans
The abolishment of current preauthorization is also
pleaded for by many respondents in this study and
forms another strong motive for levelling the exist-
ing barriers to cross-border health care. Therefore,
strong motives for further cross-border care on the
principles formulated by the European Court in the
Decker and Kohll judgements can be derived from
this study.
Cross-border health care in the ‘Euregio
Scheldemond’ (subregion ‘Zeeuws-Vlaanderen’)
Almost simultaneously, another project was set up on
behalf of the Dutch sickness fund OZ zorgverzek-
eringen to analyse, from an economic and legal per-
spective, the consequences of the Decker and Kohll
judgements on cross-border health care in the Eure-
gion Scheldemond (subregion ‘Zeeuws-Vlaanderen’)
(Ghajar et al. 1999). This Euregion covers East 
Flanders and a part of West Flanders in Belgium, and
the province of Zealand in the Netherlands. The 
subregion Zeeuws-Vlaanderen (the most southern
part of the province Zealand, south of the river 
Westerschelde in the Netherlands) is historically 
and culturally more oriented towards Flanders in
Belgium.This also includes Belgian hospital facilities.
For this reason an unofficial bilateral agreement was
made in 1978 between the Belgian and Dutch sick-
ness funds operating in that Euregion and (some)
hospitals in Belgium for the treatment of Dutch
patients in Belgian hospitals. In the beginning the
number of patients asked for permission to be
treated abroad was between 1000 and 1500. The
agreement has been changed and adapted in the
meantime and because of extended possibilities
created in 1998, 2300 first requests were administered
by the health insurers (mainly OZ zorgverzekerin-
gen, being the principal insurance fund on the Dutch
side for this subregion). This represents about 4% of
the number of sickness-fund-insured persons. Some
4% cross-border care is exceptional compared with
other (sub)regions in the Netherlands. The main
reason for this relatively high percentage is that, in
general, the level of health care facilities in this sub-
region has been less developed compared with other
regions. There is a lack of highly specialized facilities
such as neurosurgery, trauma centres, and transplan-
tation surgery (Scoop 1999). Characteristic of this
subregion is that it is a border region. The distance
from ‘Zeeuws-Vlaanderen’ to Belgium (Flanders) is
very short (nowhere more than 25 km). The combi-
nation of a lack of health care facilities and the short
distance to the Belgian border has led to the situa-
tion where the basic conditions for cross-border
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Table 2 Types of care and reasons for cross-border health care
Waiting Recommended Recommended Better More
Distance time Language Costs by GP by specialist treatment attention Total
Gynaecology 19 5 4 3 7 3 6 1 48
Orthopaedics 13 11 2 2 5 1 5 3 42
Epilepsy 4 – – 1 2 6 3 1 17
Psychotherapy 7 1 – 1 – 3 10 1 23
General surgery 21 5 4 3 9 8 12 2 64
Orthodontics 2 – – 1 1 2 3 1 10
Paediatrics 2 – 1 1 – 1 – 1 6
Ophthalmology 14 10 2 – 3 5 3 1 38
Neurosurgery 3 3 – – – 7 4 – 17
Internal medicine 14 1 1 2 9 5 3 1 36
Hospital 1 1 – – – – – – 2
Remaining 4 5 2 – 12 5 8 2 38
Total 104 42 16 14 48 46 57 14 339
Source: Ghajar S. & Hermans H.E.G.M. (1999) IZOM, Behoefte van verzekerden aan grensoverschrijdende zorg en hun ervaringen [Needs of
insured persons for cross-border care and their experiences], Eindrapport inzake het project Integratie Zorg op Maat in Interreg II, Euregio Maas-
Rijn [Final Report concerning integration Zorg op Maat in Interreg II], Rotterdam
health care are present. Therefore, the Decker and
Kohll judgements can also have a major impact on
the cross-border health care in this subregion.
A first consequence could be that the health insur-
ers (sickness funds) will no longer be able to refuse
authorization to consume health care abroad. For
that reason it could become even more attractive 
for patients to be treated in neighbouring country.
A precondition is that patients must be reimbursed.
The question is how many patients would want to
consume health care abroad, in addition to the 
large numbers of patients already leaving ‘Zeeuws-
Vlaanderen’ to look for absent health care facilities
abroad?
Within the Dutch health care system, waiting lists
form an important motive to consume health care in
another Member State (Brouwer & Hermans 1999).
Dutch research on waiting lists shows that waiting
times in curative and mental health care in the Dutch
province Zealand are, on average, 32 days, while in
the rest of the country the average is 27.7 days (Van
Wolde 1999).Therefore, excessive waiting time in the
Netherlands could constitute a reason for the sub-
region ‘Zeeuws-Vlaanderen’ to consume health care
abroad.
For these patients there is hardly any reason to be
treated within the Netherlands in another region,
because long waiting lists are also to be found there.
When, as is the case in Belgium, waiting times are
substantially shorter (or even absent) for certain spe-
cialties, it would seem attractive for the population in
‘Zeeuws-Vlaanderen’ to look for health care services
and benefits abroad, even without the preauthoriza-
tion of the insurer, which the Decker and Kohll
judgement now enables them to do. What eases this
unofficial route is the familiarity with (health care in)
Belgium. Another stimulating aspect is that the lan-
guage on both sides of the border is almost the same,
which also eases communication between doctor and
patient.
However, financially, there is a clear inhibition
towards cross-border health care without preauthori-
zation of the sickness fund. The general population
are not only relatively unacquainted with the Decker
and Kohll ruling but also of the rights that could be
derived from these judgements. The price levels of
Belgian health care services are also not as transpar-
ent as Dutch health care facilities. Under Decker and
Kohll, treatments abroad must be reimbursed against
the national (Dutch) tariffs. When some parts of the
health care services seem to be more expensive in
Belgium, the patient has to pay the difference. The
considerably higher number and amounts of co-
payments in Belgium could also form a break on
cross-border health care. At the moment these co-
payments are being paid by the sickness fund (as
kind of goodwill) when patients travel abroad with
the authorization of the sickness fund.
From the aforementioned developments it can be
concluded that there is a clear difference between the
present agreement among the sickness fund ‘OZ
zorgverzekeringen’ and the Belgian hospitals and
mutualities and the possible future consequences of
the Decker and Kohll judgements.Where the present
agreement covers the full costs for Dutch patients
against the Belgian tariffs, this is not the case when
patients cross the border without preauthorization.
This is important because the present price level of
Belgian hospitals can differ from the Dutch maxi-
mum tariffs. Also, in cases of, for example, ambula-
tory care, the total amount of care consumed by the
insured persons can rise and, as a consequence,
the total sum of costs for the health insurance fund
can also rise. While they themselves are responsible
for keeping the total costs within the budget they
receive, Dutch sickness funds, in particular those in
border areas like ‘Zeeuws-Vlaanderen’, currently
have hardly any instrument to control the costs of
care consumed outside the Netherlands. The present
contracting system provides (at least in theory) some
(legal and financial) possibilities to control the costs
and to steer the contracts made with Belgian hospi-
tals. According to the Decker and Kohll judgements,
the insured are free to be reimbursed for treatment
abroad. New court cases will show whether or not 
the Decker and Kohll doctrine is also applicable to
the hospital sector. If this is the case, a further under-
mining of the budgeting system is a real danger, par-
ticularly for the OZ zorgverzekeringen sickness fund
in Dutch ‘Zeeuws-Vlaanderen’.
Future perspectives and health 
policy conclusions
At least three new important new cases are pending
before the European Court of Justice: Smits-Geraets
Cross-border health care in the European Union
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and Peerbooms (European Court of Justice, unpub-
lished pending joint cases, C–157/99), Vanbraekel
(European Court of Justice, unpublished pending
case, C-368/98 Vanbraekel vs. ANMC) and Ferlini
(European Court of Justice, unpublished pending
case, C-411/98, Ferlini).
In the case of Smits-Geraets the Dutch sickness
fund refused to reimburse a specialist treatment for
Parkinson’s disease provided in a German clinic 
on the grounds that adequate treatment could be
provided in the Netherlands. The sickness fund
argued furthermore that the German methods added
nothing to those on offer in the Netherlands.The pre-
condition for being treated abroad for reason of
medical necessity was therefore absent.
In the Peerbooms Case, the Dutch sickness fund
refused authorization for a Dutch patient to receive
a neuro-stimulation therapy in Austria. This therapy
is still experimental in the Netherlands and could be
provided in two rehabilitation centres. It falls outside
the legally defined compulsory health insurance
package.
These pre-judicial questions put before the 
European Court of Justice are touching at the heart
of the Dutch Health Insurance System. The cases
raise new issues such as the tenability of the (Dutch)
provision criterion that the treatment must be 
customary in the circle of health professionals,
whether the Decker and Kohll judgements apply 
to ‘benefits-in-kind’ systems, and the tenability of
agreements that are made within the system and the
preauthorization for health care in other Member
States.
The Vanbraekel case concerns a Belgian-insured
patient who was treated in a French hospital without
seeking prior authorization.The Belgian Court asked
for the European Court ruling, believing that the
operation provided in the hospital was necessary.The
question here is whether or not the cost of hospital
treatment should be reimbursed on the basis of 
the rules of the competent insurance company in
Belgium or according to the rules of the Member
State where the treatment took place.
In the Ferlini case, the wife of a European civil
servant, covered by EU civil servants’ policy, gave
birth to a baby in a Luxembourg Hospital. The hos-
pital charged a higher rate than would be customary
for a Luxembourg citizen in a similar situation.
Ferlini pleaded that he was indirectly discriminated
against because of his nationality, a contravention of
the principle of equal treatment and the free move-
ment of employees.
These new cases, as well as the observed practice
in the Euregions, show that access to care is limited
by present national health legislation and health care
policies. For example, Dutch government requires
that compulsory insured persons in the Netherlands
may obtain care in another Member State as long as
the care provider has contracted with the sickness
fund of the insured person concerned.
At the moment the awareness of cross-border
rights to health care is not widespread in most Euro-
pean countries. The recent cross-border projects in
the Euregions ‘Meuse-Rhine’ and ‘Scheldemond’
have shown that even there, where the potential for
cross-border health care is greatest, the lack of ad-
equate information on cross-border care is conspic-
uous in its absence. Even where patients are well
informed about their rights, practical barriers could
prevent them travelling from abroad. As travel and
health care costs have to be paid up-front by 
the patient using the Decker and Kohll system (e.g.
co-payments), this may create a two-tier system
whereby the more wealthy patients use the Decker
and Kohll route, while others will still use the exist-
ing system of preauthorized care by using the E112
forms.
The results of the cross-border projects in the
Euregions have also shown that the new cross-border
health alliances could result in improved possibilities
for patients to have access to more health care facil-
ities than existed before, not by way of ‘Decker and
Kohll’, but through a flexible use of the existing 
E112 route. Alliances between health insurers and
providers have been approved and facilitated by the
different governmental organizations, which were
also involved in such projects.
The Decker and Kohll rulings could also be seen
as an incentive to enhance access to cross-border
health care in border areas. Rather than holding 
out against the decisions, governments could see 
the latest developments as a means of easing ever-
lengthening waiting lists. Therefore, it is not only the
legal environment that creates possibilities for cross-
border health care for patients but also, and even
more importantly, the health policy environment that
438 © 2000 Blackwell Science, Journal of Evaluation in Clinical Practice, 6, 4, 431–439
creates access to cross-border health care facilities
for patients.
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